Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats - Li, C; Lim, S C; Kim, J (Eur J Drug Metab Pharmacokinet, 2011)
et al.